Synthon Pharms Drug Patent Portfolio
Synthon Pharms owns 1 orange book drug protected by 1 US patent Given below is the list of Synthon Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6828339 | Amlodipine salt forms and processes for preparing them | 20 Nov, 2022 | Expired |
Latest Legal Activities on Synthon Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Synthon Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 07 Jan, 2013 | US6828339 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 16 Apr, 2007 | US6828339 |
|
Correspondence Address Change
Critical
| 16 Apr, 2007 | US6828339 |
|
Correspondence Address Change
Critical
| 09 Mar, 2005 | US6828339 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Dec, 2004 | US6828339 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Dec, 2004 | US6828339 |
|
Issue Notification Mailed
Critical
| 18 Nov, 2004 | US6828339 |
| Receipt into Pubs | 15 Nov, 2004 | US6828339 |
| Dispatch to FDC | 11 Nov, 2004 | US6828339 |
| Receipt into Pubs | 05 Nov, 2004 | US6828339 |
|
Application Is Considered Ready for Issue
Critical
| 29 Oct, 2004 | US6828339 |
| Miscellaneous Communication to Applicant - No Action Count | 06 Oct, 2004 | US6828339 |
| Mail Miscellaneous Communication to Applicant | 06 Oct, 2004 | US6828339 |
|
Issue Fee Payment Received
Critical
| 02 Jul, 2004 | US6828339 |
|
Issue Fee Payment Verified
Critical
| 02 Jul, 2004 | US6828339 |
Synthon Pharms's Family Patents
Synthon Pharms Drug List
Given below is the complete list of Synthon Pharms's drugs and the patents protecting them.
1. Amlodipine Besylate
Amlodipine Besylate is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6828339 | Amlodipine salt forms and processes for preparing them |
20 Nov, 2022
(1 year, 11 months ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Amlodipine Besylate's drug page